Skip to content

The effects of a DPP4 inhibitor on endothelial function in diabetic patients with coronary artery disease

The effects of a DPP4 inhibitor on endothelial function in diabetic patients with coronary artery disease - The effects of a DPP4 inhibitor on endothelium

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000008806
Enrollment
30
Registered
2012-08-30
Start date
2011-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus with coronary artery disease

Interventions

Additional treatment of Sitagliptin conventional treatment

Sponsors

Department of Cardiovascular Medicine, Faculty of Life Sciences, Kumamoto University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Type 2 diabetes mellitus (DM) patients with coronary artery disease 1. Uncontrolled DM patients with diet and exercise therapy 2. Uncontrolled DM patients treated with insulin injections or oral anti-diabetic drugs except DPP-4 inhibitors Patients with coronary artery disease documented by CAG or CT with organic coronary stenosis of >50% in major coronary arteries.

Exclusion criteria

Exclusion criteria: 1. Patients receiving GLP-1 receptor analogues injection and glinide drugs 2. Patients needed rapidly intensive glucose control 3. Patients with heart failure (New York Heart Association functional class II to IV) 4. Patients with active systemic inflammatory disease, chronic renal failure requiring hemodialysis, active hepatic disease, and presence of malignant tumor 5. Patients with acute coronary syndrome within 3 months preceding admission 6. Ineligible patients for any other reasons

Design outcomes

Primary

MeasureTime frame
Reactive hyperemia peripheral arterial tonometry index

Secondary

MeasureTime frame
High-sensitivity C-reactive Protein

Countries

Japan

Contacts

Public ContactJunichi Matsubara

Kumamoto University, Faculty of Life Sciences Department of Cardiovascular Medicine

j-matsu@kumamoto-u.ac.jp096-373-5175

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026